Ali Murad, Uddin Aziz, Ghafoor Sajid Ul, Rehman Atta Ur
Department of Zoology, Hazara University, Mansehra, Khyber Pakhtunkhwa, Pakistan.
Department of Biotechnology and Genetic Engineering, Hazara University, Mansehra, Khyber Pakhtunkhwa, Pakistan.
Genet Res (Camb). 2025 Aug 26;2025:5544418. doi: 10.1155/genr/5544418. eCollection 2025.
Breast cancer ranks among the top causes of cancer-related deaths in women around the globe, with genetic mutations in the gene being a frequent cause of breast or ovarian cancer. This study investigates hotspot mutations in exon 11 of the gene among Pakistani women diagnosed with breast cancer. Thirty clinically diagnosed breast cancer patients, all women, were enrolled in the current study, and high-quality DNA was extracted from peripheral blood samples. Two of the twenty-five successfully sequenced samples had a homozygous missense variant (c.2312T > C: p.Leu771Ser) detected by Sanger sequencing after PCR amplification. Upon investigation in the ClinVar database, the identified variant showed conflicting interpretations of pathogenicity. Demographic data highlighted an early disease onset, showing that 56% of patients were under 50 years of age. The need for genetic screening was further supported by the fact that 24% of the patients had a positive family history of cancer. Our study emphasizes the necessity of screening gene mutations to better understand the pathogenic potential of the identified variants in the Pakistani population.
乳腺癌是全球女性癌症相关死亡的主要原因之一,该基因的基因突变是乳腺癌或卵巢癌的常见病因。本研究调查了巴基斯坦乳腺癌女性患者中该基因第11外显子的热点突变。30例临床诊断为乳腺癌的患者(均为女性)纳入本研究,从外周血样本中提取高质量DNA。25个成功测序的样本中有2个在PCR扩增后经桑格测序检测到纯合错义变异(c.2312T>C:p.Leu771Ser)。在ClinVar数据库中进行调查时,所鉴定的变异对致病性显示出相互矛盾的解释。人口统计学数据突出了疾病的早期发病,表明56%的患者年龄在50岁以下。24%的患者有癌症家族史这一事实进一步支持了基因筛查的必要性。我们的研究强调了筛查该基因突变的必要性,以便更好地了解巴基斯坦人群中所鉴定变异的致病潜力。